Contract HHSD200201138143C
Medimmune Llc · Department Of Health And Human Services · March 8, 2011
Medimmune Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on March 8, 2011 for $72.64 million of work in biological product (except diagnostic) manufacturing. Performance is in Gaithersburg, MD. It was awarded under full and open competition. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 27, 2020. If all options are exercised, the contract could reach $155.79 million.
Contract details
- PIID
- HHSD200201138143C
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Gaithersburg, MD
- First action
- March 8, 2011
- Latest action
- March 27, 2020
Description
MEDIMMUNE VCF FUNDING
Modification timeline
-
March 27, 2020Mod 7$0
-
October 29, 2015Mod 6$-75.0K
-
March 6, 2013Mod 5$-1.14M
-
December 6, 2011Mod 4MEDIMMUNE VFC FLU 2012$0
-
August 26, 2011Mod 3MEDIMMUNE VFC FLU 2012$0
-
June 9, 2011Mod 2PEDIATRIC FLU VACCINE$1.57M
-
April 6, 2011Mod 1PEDIATRIC FLU VACCINE$71.38M
-
March 8, 2011Base awardPEDIATRIC FLU VACCINE$900.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200201138143C?
Contract HHSD200201138143C is a federal contract awarded to Medimmune Llc by Department Of Health And Human Services on March 8, 2011 for $72.64 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 7 times since the base award.
Who won contract HHSD200201138143C?
Medimmune Llc won contract HHSD200201138143C from Department Of Health And Human Services.
How much is contract HHSD200201138143C worth?
Contract HHSD200201138143C has obligated $72.64 million to date, with a total potential value of $155.79 million if all options are exercised.